Loading…
NLRP3 inflammasome, a target for therapy in diverse disease states
A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout...
Saved in:
Published in: | European journal of immunology 2010-03, Vol.40 (3), p.631-634 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83 |
---|---|
cites | cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83 |
container_end_page | 634 |
container_issue | 3 |
container_start_page | 631 |
container_title | European journal of immunology |
container_volume | 40 |
creator | Cook, Graham P Savic, Sinisa Wittmann, Miriam McDermott, Michael F |
description | A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate. |
doi_str_mv | 10.1002/eji.200940162 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733696969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733696969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</originalsourceid><addsrcrecordid>eNp9kMFPwjAUhxujEUSPXnU3Lw5f27F2RyWoGKJG5dw82SuObAzboeG_twQknsw7_C7f-w4fY6ccuhxAXNGs6AqALAGeij3W5j3B44QnfJ-1AXgSi0xDix15P4OApb3skLUECODAdZvdPI5enmVUzG2JVYW-rugywqhBN6UmsrWLmg9yuFgFJMqLL3KewnrCsL7BhvwxO7BYejrZboeNbwdv_ft49HQ37F-P4kmSZiImaVWSSJVJ0hPU1iqtkSuulUTNhdZEubaQ95RKSaaIlKc9SaBBI_Jcyw672HgXrv5ckm9MVfgJlSXOqV56o6RMs_UFMt6QE1d778iahSsqdCvDwayrmVDN7KoF_mxrXr5XlO_o30wBUBvguyhp9b_NDB6Gf9Xnm0-LtcGpK7wZvwarDFqeaEjlDwdmf6Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733696969</pqid></control><display><type>article</type><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><source>Wiley</source><creator>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</creator><creatorcontrib>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</creatorcontrib><description>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.200940162</identifier><identifier>PMID: 20201018</identifier><language>eng</language><publisher>Weinheim: Wiley-VCH Verlag</publisher><subject>Animals ; Autoimmune Diseases - immunology ; Autoinflammatory ; Cancer ; Carrier Proteins - immunology ; Dermatitis, Contact - immunology ; Diabetes Mellitus, Type 2 - immunology ; Humans ; IL‐1 inhibition ; Immunity, Innate ; Inflammasome ; Inflammation - immunology ; Liver ; Multiprotein Complexes - immunology ; Neoplasms - immunology ; NLR Family, Pyrin Domain-Containing 3 Protein</subject><ispartof>European journal of immunology, 2010-03, Vol.40 (3), p.631-634</ispartof><rights>Copyright © 2010 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</citedby><cites>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20201018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cook, Graham P</creatorcontrib><creatorcontrib>Savic, Sinisa</creatorcontrib><creatorcontrib>Wittmann, Miriam</creatorcontrib><creatorcontrib>McDermott, Michael F</creatorcontrib><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</description><subject>Animals</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoinflammatory</subject><subject>Cancer</subject><subject>Carrier Proteins - immunology</subject><subject>Dermatitis, Contact - immunology</subject><subject>Diabetes Mellitus, Type 2 - immunology</subject><subject>Humans</subject><subject>IL‐1 inhibition</subject><subject>Immunity, Innate</subject><subject>Inflammasome</subject><subject>Inflammation - immunology</subject><subject>Liver</subject><subject>Multiprotein Complexes - immunology</subject><subject>Neoplasms - immunology</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kMFPwjAUhxujEUSPXnU3Lw5f27F2RyWoGKJG5dw82SuObAzboeG_twQknsw7_C7f-w4fY6ccuhxAXNGs6AqALAGeij3W5j3B44QnfJ-1AXgSi0xDix15P4OApb3skLUECODAdZvdPI5enmVUzG2JVYW-rugywqhBN6UmsrWLmg9yuFgFJMqLL3KewnrCsL7BhvwxO7BYejrZboeNbwdv_ft49HQ37F-P4kmSZiImaVWSSJVJ0hPU1iqtkSuulUTNhdZEubaQ95RKSaaIlKc9SaBBI_Jcyw672HgXrv5ckm9MVfgJlSXOqV56o6RMs_UFMt6QE1d778iahSsqdCvDwayrmVDN7KoF_mxrXr5XlO_o30wBUBvguyhp9b_NDB6Gf9Xnm0-LtcGpK7wZvwarDFqeaEjlDwdmf6Y</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Cook, Graham P</creator><creator>Savic, Sinisa</creator><creator>Wittmann, Miriam</creator><creator>McDermott, Michael F</creator><general>Wiley-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201003</creationdate><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><author>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoinflammatory</topic><topic>Cancer</topic><topic>Carrier Proteins - immunology</topic><topic>Dermatitis, Contact - immunology</topic><topic>Diabetes Mellitus, Type 2 - immunology</topic><topic>Humans</topic><topic>IL‐1 inhibition</topic><topic>Immunity, Innate</topic><topic>Inflammasome</topic><topic>Inflammation - immunology</topic><topic>Liver</topic><topic>Multiprotein Complexes - immunology</topic><topic>Neoplasms - immunology</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cook, Graham P</creatorcontrib><creatorcontrib>Savic, Sinisa</creatorcontrib><creatorcontrib>Wittmann, Miriam</creatorcontrib><creatorcontrib>McDermott, Michael F</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cook, Graham P</au><au>Savic, Sinisa</au><au>Wittmann, Miriam</au><au>McDermott, Michael F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NLRP3 inflammasome, a target for therapy in diverse disease states</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>40</volume><issue>3</issue><spage>631</spage><epage>634</epage><pages>631-634</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</abstract><cop>Weinheim</cop><pub>Wiley-VCH Verlag</pub><pmid>20201018</pmid><doi>10.1002/eji.200940162</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2010-03, Vol.40 (3), p.631-634 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_733696969 |
source | Wiley |
subjects | Animals Autoimmune Diseases - immunology Autoinflammatory Cancer Carrier Proteins - immunology Dermatitis, Contact - immunology Diabetes Mellitus, Type 2 - immunology Humans IL‐1 inhibition Immunity, Innate Inflammasome Inflammation - immunology Liver Multiprotein Complexes - immunology Neoplasms - immunology NLR Family, Pyrin Domain-Containing 3 Protein |
title | NLRP3 inflammasome, a target for therapy in diverse disease states |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T12%3A02%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NLRP3%20inflammasome,%20a%20target%20for%20therapy%20in%20diverse%20disease%20states&rft.jtitle=European%20journal%20of%20immunology&rft.au=Cook,%20Graham%20P&rft.date=2010-03&rft.volume=40&rft.issue=3&rft.spage=631&rft.epage=634&rft.pages=631-634&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.200940162&rft_dat=%3Cproquest_cross%3E733696969%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733696969&rft_id=info:pmid/20201018&rfr_iscdi=true |